Madrigal Pharmaceuticals (MDGL) Debt Ratio (2010 - 2026)

Madrigal Pharmaceuticals (MDGL) has 12 years of Debt Ratio data on file, last reported at 0.28 in Q1 2026.

• On a quarterly basis, Debt Ratio rose 134.19% year-over-year to 0.28 in Q1 2026; TTM through Mar 2026 was 0.28, a 134.19% increase from a year earlier, with the FY2025 full-year figure at 0.27, up 139.21% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.28, up from 0.27 in the prior quarter.
• Over the last five years, Debt Ratio for MDGL reached as high as 0.63 in Q3 2023 and fell as low as 0.11 in Q2 2024.
• Historically, Debt Ratio has averaged 0.23 across 5 years, with a median of 0.2 in 2022.
• Across the five-year window, Debt Ratio plunged 82.56% in 2024 and jumped 139.21% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.14 in 2022, then jumped by 32.62% to 0.18 in 2023, then slumped by 37.43% to 0.11 in 2024, then surged by 139.21% to 0.27 in 2025, then advanced by 2.76% to 0.28 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.28 in Q1 2026, 0.27 in Q4 2025, and 0.25 in Q3 2025.